128 related articles for article (PubMed ID: 3512817)
21. In vivo evidence for a direct effect of naloxone on testicular steroidogenesis in the male rat.
Cicero TJ; Adams ML; O'Connor LH; Nock B
Endocrinology; 1989 Aug; 125(2):957-63. PubMed ID: 2666108
[TBL] [Abstract][Full Text] [Related]
22. Characterization and possible opioid modulation of N-methyl-D-aspartic acid induced increases in serum luteinizing hormone levels in the developing male rat.
Cicero TJ; Meyer ER; Bell RD
Life Sci; 1988; 42(18):1725-32. PubMed ID: 3283488
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of opiate-induced depressions in serum luteinizing hormone levels by the prior administration of naloxone in the male rat.
Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
Life Sci; 1984 Sep; 35(12):1321-8. PubMed ID: 6090834
[TBL] [Abstract][Full Text] [Related]
24. Disappearance of opioidergic tone on LH secretion in underfed prepubertal sheep.
Recabarren SE; Zapata P; Parilo J
Horm Metab Res; 1990 Apr; 22(4):225-8. PubMed ID: 2190902
[TBL] [Abstract][Full Text] [Related]
25. Relation of gonadal hormones to differential LH response to naloxone in prepubertal male and female rats.
Sylvester PW; Sarkar DK; Briski KP; Meites J
Neuroendocrinology; 1985 Feb; 40(2):165-70. PubMed ID: 3974796
[TBL] [Abstract][Full Text] [Related]
26. Hormone ontogeny in the ovine fetus. XVIII. The effect of an opioid antagonist on luteinizing hormone secretion.
Cuttler L; Egli CA; Styne DM; Kaplan SL; Grumbach MM
Endocrinology; 1985 May; 116(5):1997-2002. PubMed ID: 3987627
[TBL] [Abstract][Full Text] [Related]
27. Interaction between gabaergic and opioid pathways in the regulation of gonadotropin secretion in males.
Elias AN; Kyaw T; Stone S; Weathersbee P; Iyer K; Ascher MS
Horm Metab Res; 1986 Dec; 18(12):838-41. PubMed ID: 3102338
[TBL] [Abstract][Full Text] [Related]
28. Endogenous opioids and the control of seasonal LH secretion in Soay rams.
Ebling FJ; Lincoln GA
J Endocrinol; 1985 Dec; 107(3):341-53. PubMed ID: 4067489
[TBL] [Abstract][Full Text] [Related]
29. Analysis of estradiol-independent and -dependent endogenous opioid peptide suppression of pulsatile LH release between the mornings of diestrus 2 and proestrus in the rat estrous cycle.
Babu GN; Bona-Gallo A; Gallo RV
Brain Res Bull; 1988 Aug; 21(2):277-84. PubMed ID: 3191412
[TBL] [Abstract][Full Text] [Related]
30. Hypothalamic opioid mechanisms in experimental uremic hypogonadism.
Dong QH; Handelsman DJ
Endocrinology; 1990 Mar; 126(3):1498-503. PubMed ID: 2137774
[TBL] [Abstract][Full Text] [Related]
31. Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by corticotropin-releasing factor.
Almeida OF; Nikolarakis KE; Herz A
Endocrinology; 1988 Mar; 122(3):1034-41. PubMed ID: 3257730
[TBL] [Abstract][Full Text] [Related]
32. Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring.
Cicero TJ; Adams ML; Giordano A; Miller BT; O'Connor L; Nock B
J Pharmacol Exp Ther; 1991 Mar; 256(3):1086-93. PubMed ID: 2005573
[TBL] [Abstract][Full Text] [Related]
33. Declining plasma progesterone levels eliminate endogenous opioid peptide suppression of LH pulse frequency on day 22 of gestation in the rat.
Devorshak-Harvey E; Bona-Gallo A; Gallo RV
Neuroendocrinology; 1988 Dec; 48(6):584-90. PubMed ID: 3075015
[TBL] [Abstract][Full Text] [Related]
34. Gonadal steroid modulation of brain opioid systems.
Limonta P; Maggi R; Dondi D; Martini L; Piva F
J Steroid Biochem; 1987; 27(4-6):691-8. PubMed ID: 2826902
[TBL] [Abstract][Full Text] [Related]
35. Postpubertal maturation of endogenous opioid regulation of luteinizing hormone secretion in the female sheep.
Schall RE; Ebling FJ; Karsch FJ; Foster DL
Biol Reprod; 1991 May; 44(5):760-8. PubMed ID: 1868135
[TBL] [Abstract][Full Text] [Related]
36. One month of streptozotocin-diabetes induces different neuroendocrine and morphological alterations in the hypothalamo-pituitary axis of male and female rats.
Bestetti G; Locatelli V; Tirone F; Rossi GL; Müller EE
Endocrinology; 1985 Jul; 117(1):208-16. PubMed ID: 3891314
[TBL] [Abstract][Full Text] [Related]
37. Effect of naloxone and beta-casomorphin on the hypothalamic-pituitary-luteinizing hormone axis in vitro.
Shacoori V; Guerin J; Girre A; Saïag B; Rault B
Life Sci; 1992; 51(12):899-907. PubMed ID: 1518367
[TBL] [Abstract][Full Text] [Related]
38. Opioidergic control of luteinizing hormone secretion in the female rabbit: influence of age on the response to naloxone.
YoungLai EV; Wilkinson M; Thompson N; Byrne A
Can J Physiol Pharmacol; 1988 Jan; 66(1):38-42. PubMed ID: 3130973
[TBL] [Abstract][Full Text] [Related]
39. Opioid modulation of tonic luteinizing hormone release in ovariectomized dairy cows.
Nanda AS; Ward WR; Dobson H
J Vet Pharmacol Ther; 1989 Dec; 12(4):397-403. PubMed ID: 2614857
[TBL] [Abstract][Full Text] [Related]
40. Effect of naloxone and morphine on LH and prolactin release in androgen-sterilized rats.
Petersen SL; Barraclough CA
Neuroendocrinology; 1986; 44(1):84-8. PubMed ID: 3785576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]